https://scholars.lib.ntu.edu.tw/handle/123456789/487281
標題: | Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy | 作者: | BANG-BIN CHEN CHAO-YU HSU CHIH-WEI YU PO-CHIN LIANG CHIUN HSU CHIH-HUNG HSU ANN-LII CHENG TIFFANY TING-FANG SHIH |
公開日期: | 2016 | 出版社: | Radiological Society of North America Inc. | 卷: | 281 | 期: | 2 | 起(迄)頁: | 454-464 | 來源出版物: | Radiology | 摘要: | Purpose: To retrospectively compare the perfusion parameters of advanced hepatocellular carcinoma (HCC) measured with dynamic contrast material-enhanced (DCE) magnetic resonance (MR) imaging with surrounding liver parenchyma to determine the relationship between these parameters and uncensored overall survival (OS). Materials and Methods: This retrospective study had institutional review board approval, and informed consent was waived. DCE MR imaging was performed in 92 patients with advanced HCC before systemic treatment was administered (19 patients received a placebo). Three semiquantitative (peak, slope, and area under the gadolinium concentration-time curve [AUC]) and six quantitative (arterial fraction, arterial flow, portal flow, total blood flow, distribution volume, and mean transit time) parameters were calculated by placing regions of interest in the largest area of the tumor and background liver parenchyma. The DCE MR imaging parameters between the tumor and normal liver were compared with paired Wilcoxon test. By using the Cox proportional hazards model for univariate and multivariate analyses, the association of DCE MR imaging parameters and OS was investigated. Results: HCC demonstrated significantly higher peak, slope, AUC, arterial fraction, and arterial flow but lower portal flow, distribution volume, and mean transit time than did the background liver (all P< .05). Patients with high peak in the tumor had longer OS (P = .005) than did those with low peak. Cox multivariate analysis identified peak as an independent predictor of OS (P = .032) after adjusting for age, sex, treatment, tumor size, and portal vein thrombosis. Conclusion: DCE MR imaging parameters can be used to differentiate advanced HCC from the background liver, and peak, a semiquantitative parameter, is associated with outcome in patients with advanced HCC before systemic therapy. ? RSNA, 2016. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84992163560&doi=10.1148%2fradiol.2016152659&partnerID=40&md5=8dd28767e85ddc5bfa21a1b4fc69fc5e https://scholars.lib.ntu.edu.tw/handle/123456789/487281 |
ISSN: | 0033-8419 | DOI: | 10.1148/radiol.2016152659 | SDG/關鍵字: | gadodiamide; placebo; sorafenib; tegafur; uracil; vandetanib; antineoplastic agent; contrast medium; gadolinium pentetate; adult; advanced cancer; age; aged; cancer chemotherapy; cancer mortality; cancer prognosis; cancer survival; comparative study; controlled study; disease association; dynamic contrast-enhanced magnetic resonance imaging; female; gender; human; liver cell carcinoma; liver parenchyma; major clinical study; male; overall survival; phase 2 clinical trial (topic); portal vein thrombosis; priority journal; retrospective study; Review; risk factor; survival time; systemic therapy; tumor volume; Carcinoma, Hepatocellular; diagnostic imaging; Liver Neoplasms; middle aged; nuclear magnetic resonance imaging; pathology; procedures; survival rate; treatment outcome; very elderly; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Contrast Media; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。